论文信息 - A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma - 字舞流文

A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma

Jonathan B. Mitchem | J. Picus | A. Lockhart | R. Suresh | W. Hawkins | P. Goedegebuure | P. O. Simon | B. Tan | A. Wang-Gillam | J. Mitchem | S. Sorscher | John R. Hornick | Stacey M. Plambeck-Suess